Clinical Trial Update: Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating valproate alone or with quetiapine for severe COVID-19 pneumonia with agitated delirium has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperactive Delirium
• Pneumonia Viral

Drugs mentioned

• Quetiapine (quetiapine)
• Valproate (valproate)

Snippet

Sponsor: University of Miami | Conditions: Covid19, Hyperactive Delirium | Phase 4 | Status: WITHDRAWN